Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Lowering increased cholesterol--prolonging life?].

H Klepzig1, M Kaltenbach

  • 1Abteilung für Kardiologie, Universität Frankfurt a. M.

Versicherungsmedizin
|December 11, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Angina pectoris in consequence of subtotal subclavian artery stenosis 2 years after CABG.

The Thoracic and cardiovascular surgeon·2010
Same author

[Familial Mediterranean fever (familial paraoxysmal polyserositis)].

Deutsche medizinische Wochenschrift (1946)·2003
Same author

Lipid-lowering treatment in coronary artery disease: a survey in an ambulatory outpatient clinic.

International journal of clinical pharmacology and therapeutics·2002
Same author

Effect of atenolol and celiprolol on acetylcholine-induced coronary vasomotion in coronary artery disease.

The American journal of cardiology·2000
Same author

[Clinic internal hypertext information system].

Deutsche medizinische Wochenschrift (1946)·1999
Same author

[Determinants of treatment costs of unstable angina pectoris].

Zeitschrift fur Kardiologie·1999
Same journal

[What do company health insurance plans provide?]

Versicherungsmedizin·2017
Same journal

[Assessment of prescriptive therapies and remedies - Experience and results].

Versicherungsmedizin·2017
Same journal

[The importance of biosimilars medicines for private and statutory health insurance].

Versicherungsmedizin·2017
Same journal

[Can we transfer the mechanisms of the generics market to biosimilars?]

Versicherungsmedizin·2017
Same journal

[Not Available].

Versicherungsmedizin·2016
Same journal

[Not Available].

Versicherungsmedizin·2016
See all related articles

Lowering serum cholesterol reduces non-fatal coronary events by 2% per 1% reduction. However, cholesterol-lowering measures do not prolong life expectancy due to increased non-cardiac mortality.

Area of Science:

  • Cardiovascular epidemiology
  • Clinical intervention trials
  • Public health

Context:

  • Epidemiologic studies show a link between high serum cholesterol and coronary artery disease.
  • Intervention trials investigate the effects of cholesterol reduction on health outcomes.

Purpose:

  • To evaluate the impact of cholesterol-lowering interventions on coronary events and overall mortality.
  • To determine if cholesterol reduction strategies improve life expectancy.

Summary:

  • A 1% decrease in serum cholesterol correlates with a 2% reduction in non-fatal coronary events.
  • Fatal coronary events are minimally affected by cholesterol-lowering measures.
  • Intervention groups experienced increased mortality from non-cardiac causes like cancer and accidents.

Related Experiment Videos

Impact:

  • Cholesterol reduction effectively lowers non-fatal cardiovascular events but does not extend lifespan.
  • Current cholesterol-lowering strategies may carry risks of increased non-cardiac mortality.
  • Further research is needed to balance cardiovascular benefits against non-cardiac risks.